A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation

Authors
Category Primary study
Year 2007
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: efeff30eeb9cf3f9a7032a5755f3784c23a1f766
First added on: Apr 19, 2023